|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Fixed maturity securities, available for sale, at fair value (amortized cost, net 2026, $6,125.5; 2025, $6,026.7) | ||||||||||||||||||||
| Equity securities at fair value, (cost 2026, $56200000 and 2025, $56220000) | ||||||||||||||||||||
| Limited partnership interests (Carried Under Fair Value Option, 2026, $26900000 and 2025, $0) | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Short-term and other investments | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Reinsurance balances receivable | ||||||||||||||||||||
| Deposit asset on reinsurance | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Separate Account variable annuity assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Policy liabilities | ||||||||||||||||||||
| Future policy benefit reserves | ||||||||||||||||||||
| Policyholders' account balances | ||||||||||||||||||||
| Unpaid claims and claim expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Total policy liabilities | ||||||||||||||||||||
| Other policyholder funds | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Separate Account variable annuity liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, $0.001 par value, authorized 1,000,000 shares; none issued | ||||||||||||||||||||
| Common stock, $0.001 par value, authorized 75,000,000 shares; issued, 2026, 67,580,562; 2025, 67,323,929 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax: | ||||||||||||||||||||
| Net unrealized investment losses on fixed maturity securities | ||||||||||||||||||||
| Net reserve remeasurements attributable to discount rates | ||||||||||||||||||||
| Net funded status of benefit plans | ||||||||||||||||||||
| Treasury stock, at cost, 2026, 27,086,418 shares; 2025, 26,664,472 shares | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
